Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
Public ClinicalTrials.gov record NCT05665699. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multiple-Dose Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
D-0120 is being tested in combination with Allopurinol in adult subjects with Gout.
Study identification
- NCT ID
- NCT05665699
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2023 (Actual)
- Primary completion
- Jul 31, 2025 (Actual)
- Completion
- Dec 30, 2025 (Actual)
- Last update posted
- Jul 9, 2026
2023 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Center | Birmingham | Alabama | 35233 | — |
| Site Center | Plantation | Florida | 33324 | — |
| Study Center | Evergreen Park | Illinois | 60805 | — |
| Study Center | Brownsburg | Indiana | 46254 | — |
| Site Center | Louisville | Kentucky | 40205 | — |
| Study Center | Hickory | North Carolina | 28601 | — |
| Study Center | Rocky Mount | North Carolina | 27804 | — |
| Study Center | Salisbury | North Carolina | 28144 | — |
| Study Center | Wilmington | North Carolina | 28401 | — |
| Study Center | Winston-Salem | North Carolina | 27103 | — |
| Study Center | Scottdale | Pennsylvania | 15683 | — |
| Study Center | Bristol | Tennessee | 37620 | — |
| Site Center | Hendersonville | Tennessee | 37075 | — |
| Study Center | Knoxville | Tennessee | 37909 | — |
| Site Center | Fort Worth | Texas | 76109 | — |
| Site Center | The Woodlands | Texas | 77382 | — |
| Site Center | Richmond | Virginia | 23219 | — |
| Site Center | Bellevue | Washington | 98004 | — |
| Study Center | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05665699, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05665699 live on ClinicalTrials.gov.